These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 2469911)

  • 1. Actions and interactions of G-CSF, LIF, and IL-6 on normal and leukemic murine cells.
    Metcalf D
    Leukemia; 1989 May; 3(5):349-55. PubMed ID: 2469911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal analysis of the actions of the murine leukemia inhibitory factor on leukemic and normal murine hemopoietic cells.
    Metcalf D; Hilton DJ; Nicola NA
    Leukemia; 1988 Apr; 2(4):216-21. PubMed ID: 2452326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncostatin M is a differentiation factor for myeloid leukemia cells.
    Bruce AG; Hoggatt IH; Rose TM
    J Immunol; 1992 Aug; 149(4):1271-5. PubMed ID: 1380037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal suppression of HL60 and U937 cells by recombinant human leukemia inhibitory factor in combination with GM-CSF or G-CSF.
    Maekawa T; Metcalf D
    Leukemia; 1989 Apr; 3(4):270-6. PubMed ID: 2467145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth of CD34+ acute myeloblastic leukemia colony-forming cells in response to recombinant hematopoietic growth factors.
    Carlo-Stella C; Mangoni L; Almici C; Frassoni F; Fiers W; Rizzoli V
    Leukemia; 1990 Aug; 4(8):561-6. PubMed ID: 1697011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro expansion of murine hematopoietic progenitor cells by leukemia inhibitory factor, stem cell factor, and interleukin-1 beta.
    Imamura M; Zhu X; Han M; Kobayashi M; Hashino S; Tanaka J; Kobayashi S; Kasai M; Asaka M
    Exp Hematol; 1996 Sep; 24(11):1280-8. PubMed ID: 8862438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine flt3 ligand protects M1 leukemic cells from LIF-induced differentiation and suppression of self-renewal.
    Begley CG; Rasko JE; Curtis D; Takagi K; Metcalf D; Hilton D; Roberts B; Nicola NA; Rossner MT
    Exp Hematol; 1996 Aug; 24(10):1247-57. PubMed ID: 8765501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-proliferative effect of IFN-gamma in immune regulation. II. IFN-gamma inhibits the proliferation of murine bone marrow cells stimulated with IL-3, IL-4, or granulocyte-macrophage colony-stimulating factor.
    Gajewski TF; Goldwasser E; Fitch FW
    J Immunol; 1988 Oct; 141(8):2635-42. PubMed ID: 2971726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination.
    Lemoli RM; Gulati SC; Strife A; Lambek C; Perez A; Clarkson BD
    Leukemia; 1991 May; 5(5):386-91. PubMed ID: 1709711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pleiotropic actions of leukemia inhibitory factor.
    Gough NM; Williams RL
    Cancer Cells; 1989 Nov; 1(3):77-80. PubMed ID: 2518284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced suppression of human myeloid leukemic cell lines by combinations of IL-6, LIF, GM-CSF and G-CSF.
    Maekawa T; Metcalf D; Gearing DP
    Int J Cancer; 1990 Feb; 45(2):353-8. PubMed ID: 1689277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bipotential murine hemopoietic cell line (NFS-60) that is responsive to IL-3, GM-CSF, G-CSF, and erythropoietin.
    Hara K; Suda T; Suda J; Eguchi M; Ihle JN; Nagata S; Miura Y; Saito M
    Exp Hematol; 1988 May; 16(4):256-61. PubMed ID: 2452092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic and antagonistic effects of recombinant human interleukin (IL) 3, IL-1 alpha, granulocyte and macrophage colony-stimulating factors (G-CSF and M-CSF) on the growth of GM-CSF-dependent leukemic cell lines.
    Santoli D; Yang YC; Clark SC; Kreider BL; Caracciolo D; Rovera G
    J Immunol; 1987 Nov; 139(10):3348-54. PubMed ID: 3500218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clonal response of murine myelomonocytic leukemia cells (WEHI-3B-Y1) to purified recombinant human hemopoietic factors in serum-free culture].
    Kajigaya Y; Sasaki H; Ikuta K; Matsuyama S
    Nihon Ketsueki Gakkai Zasshi; 1989 Aug; 52(5):835-41. PubMed ID: 2480048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human interleukin for DA cells (HILDA) does not affect the proliferation and differentiation of hematopoietic progenitor cells in human long-term bone marrow cultures.
    Schaafsma MR; Falkenburg JH; Duinkerken N; Moreau JF; Soulillou JP; Willemze R; Fibbe WE
    Exp Hematol; 1992 Jan; 20(1):6-10. PubMed ID: 1577095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic suppression of the clonogenicity of U937 leukemic cells by combinations of recombinant human interleukin 4 and granulocyte colony-stimulating factor.
    Maekawa T; Sonoda Y; Kuzuyama Y; Inazawa J; Kimura S; Nakamichi K; Abe T
    Exp Hematol; 1992 Nov; 20(10):1201-7. PubMed ID: 1385197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical properties of differentiation factors for murine myelomonocytic leukemic cells in organ conditioned media--separation from colony-stimulating factors.
    Nicola NA; Metcalf D
    J Cell Physiol; 1981 Nov; 109(2):253-64. PubMed ID: 6975280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of hematopoietic regulatory factors in cultures of adult and fetal mouse organs: measurement by specific bioassays.
    Metcalf D; Willson TA; Hilton DJ; Di Rago L; Mifsud S
    Leukemia; 1995 Sep; 9(9):1556-64. PubMed ID: 7544853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of differentiation of murine progenitor cells derived from blast cell colonies under serum-deprived conditions.
    Migliaccio G; Migliaccio AR; Kaushansky K; Adamson JW
    Exp Hematol; 1989 Feb; 17(2):110-5. PubMed ID: 2463929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro actions on hemopoietic cells of recombinant murine GM-CSF purified after production in Escherichia coli: comparison with purified native GM-CSF.
    Metcalf D; Burgess AW; Johnson GR; Nicola NA; Nice EC; DeLamarter J; Thatcher DR; Mermod JJ
    J Cell Physiol; 1986 Sep; 128(3):421-31. PubMed ID: 3528176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.